Protalix BioTherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PLX and other ETFs, options, and stocks.

About PLX

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. 

CEO
Dror Bashan
CEODror Bashan
Employees
226
Employees226
Headquarters
Hackensack, New Jersey
HeadquartersHackensack, New Jersey
Founded
1993
Founded1993
Employees
226
Employees226

PLX Key Statistics

Market cap
213.11M
Market cap213.11M
Price-Earnings ratio
11.76
Price-Earnings ratio11.76
Dividend yield
Dividend yield
Average volume
732.24K
Average volume732.24K
High today
$2.66
High today$2.66
Low today
$2.60
Low today$2.60
Open price
$2.64
Open price$2.64
Volume
401.54K
Volume401.54K
52 Week high
$3.19
52 Week high$3.19
52 Week low
$1.52
52 Week low$1.52

Stock Snapshot

Protalix BioTherapeutics(PLX) stock is priced at $2.65, giving the company a market capitalization of 213.11M. It carries a P/E multiple of 11.76.

On 2026-09-08, Protalix BioTherapeutics(PLX) stock moved within a range of $2.60 to $2.66. With shares now at $2.65, the stock is trading +1.7% above its intraday low and -0.6% below the session's peak.

Trading activity shows a volume of 401.54K, compared to an average daily volume of 732.24K.

Over the past 52 weeks, Protalix BioTherapeutics(PLX) stock has traded between a high of $3.19 and a low of $1.52.

Over the past 52 weeks, Protalix BioTherapeutics(PLX) stock has traded between a high of $3.19 and a low of $1.52.

People also own

Based on the portfolios of people who own PLX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.